qualit
quantit
abnorm
protein
nonprotein
compon
serum
plasma
patient
multipl
sclerosi
subject
numer
report
review
mani
recent
observ
document
evalu
conclud
present
welter
inform
gather
contribut
major
coher
way
understand
etiolog
pathogenesi
disord
sever
abnorm
observ
may
futur
candid
biochem
marker
multipl
sclerosi
present
none
suffici
reliabl
distinct
easili
perform
warrant
statu
use
diagnost
prognost
test
p
ossibl
abnorm
serum
plasma
compon
patient
multipl
sclerosi
ms
attract
attent
mani
investig
impetu
behind
studi
twofold
first
hope
better
understand
caus
pathogenesi
ms
emerg
second
search
sensit
specif
diagnost
prognost
indic
review
attempt
document
evalu
mani
abnorm
serum
plasma
constitu
observ
number
abnorm
erythrocyt
white
blood
cell
cerebrospin
fluid
patient
ms
also
report
contribut
understand
disord
cover
review
unless
relat
directli
alter
composit
serum
plasma
larg
number
public
touch
aspect
subject
review
process
select
necessari
mani
relev
articl
publish
includ
polici
appli
particular
stringenc
report
concern
immunerespons
patient
ms
topic
comprehens
review
iivanainen
correspond
dr
h
c
ford
divis
chemic
patholog
depart
laboratori
servic
wellington
hospit
wellington
new
zealand
origin
manuscript
receiv
april
revis
manuscript
receiv
june
accept
public
june
nonprotein
compon
lipid
cerebrosid
serum
normal
mainli
glucocerebrosid
minor
percentag
galactocerebrosid
revers
true
brain
myelin
cerebrospin
fluid
csf
galactocerebrosid
predomin
csf
cerebrosid
found
consist
elev
stage
ms
find
characterist
chang
number
individu
lipid
lipid
class
concept
increas
serum
concentr
galactocerebrosid
might
reflect
destruct
central
nervou
system
cn
investig
small
number
patient
control
conflict
result
jone
cowork
unabl
demonstr
differ
cerebrosid
composit
level
either
pool
plasma
larg
number
patient
ms
normal
control
individu
sampl
five
patient
agematch
control
even
stroke
patient
rel
major
destruct
cn
occur
percent
total
cerebrosid
plasma
due
galactocerebrosid
differ
significantli
percent
found
control
hand
baumann
et
al
note
elev
plasma
level
galactocerebrosid
patient
ms
stroke
patient
tent
conclud
consist
increas
csf
galactocerebrosid
level
observ
patient
ms
often
accompani
compar
chang
plasma
level
gangliosid
also
major
constitu
myelin
elev
level
gangliosidederiv
nacetylneuramin
acid
found
csf
patient
ms
also
shown
rabbit
gangliosid
move
rapidli
csf
plasma
sela
et
al
report
signific
increas
concentr
gangliosidebound
sialic
acid
pool
serum
patient
clinic
definit
ms
ml
compar
concentr
pool
serum
number
ford
healthi
blood
donor
ml
pattern
individu
gangliosid
two
pool
sera
ident
also
found
peripher
blood
lymphocyt
ms
patient
contain
averag
gangliosid
lymphocyt
control
group
observ
interest
sinc
gangliosid
shown
alter
immun
respons
lymphocyt
vitro
work
need
assess
role
blood
csf
gangliosid
play
alter
immun
respons
characterist
mani
patient
ms
although
earli
literatur
contradictori
regard
phospholipid
composit
serum
ms
review
refer
later
worker
agre
neither
total
individu
phospholipid
content
serum
ms
patient
differ
normal
report
increas
lysolecithin
concentr
plasma
ms
patient
compar
normal
subject
probabl
nonspecif
consequ
ill
sinc
two
group
could
find
differ
ms
patient
compar
patient
neurolog
diseas
definit
conclus
reach
concern
zinc
statu
compartment
ms
patient
recent
studi
suggest
concentr
copper
serum
whole
blood
normal
ms
patient
report
decreas
percentag
total
serum
fatti
acid
due
linol
acid
ms
patient
especi
exacerb
go
back
least
rel
decreas
cholesterol
linol
increas
triand
tetraunsatur
fatti
acid
ester
cholesterol
also
observ
ms
patient
especi
progress
stage
diseas
love
cowork
found
decreas
linol
acid
content
serum
lipid
gener
phenomenon
ill
patient
specif
ms
sever
group
also
unabl
find
characterist
abnorm
total
cholesterolesterifi
linol
acid
concentr
ms
serum
ms
patient
appar
show
consist
decreas
level
linol
arachidon
acid
csf
howev
pathophysiolog
signific
find
unclear
possibl
abnorm
linol
metabol
ms
patient
attract
consider
interest
controversi
diagnost
test
ms
depend
characterist
decreas
electrophoret
mobil
erythrocyt
ms
patient
presenc
linol
acid
possibl
therapeut
valu
linol
supplement
diet
report
increas
plasma
concentr
alanin
arginin
decreas
plasma
concentr
tryptophan
leucin
isoleucin
valin
tyrosin
phenylalanin
ms
patient
confirm
third
group
use
serum
latter
investig
observ
elev
serum
glutam
concentr
strike
relaps
geograph
factor
may
contribut
dispar
result
sinc
report
origin
japan
itali
unit
state
respect
furthermor
known
concentr
glutamin
asparagin
decreas
concentr
aspart
glutam
increas
serum
rel
plasma
serum
folat
level
found
significantli
lower
patient
ms
group
patient
nonneurolog
diseas
report
howev
variabl
degre
folat
defici
may
accompani
varieti
chronic
neurolog
diseas
serum
vitamin
e
level
ms
patient
found
normal
result
studi
concentr
zinc
peripher
blood
patient
multipl
sclerosi
conflict
tabl
obviou
explan
discord
result
differ
type
sampl
analyz
name
serum
plasma
erythrocyt
whole
blood
data
obtain
high
incid
abnorm
pattern
paper
chromatogram
serum
protein
patient
ms
report
mani
year
ago
abnorm
pattern
tend
recur
cycl
month
clearli
relat
clinic
activ
diseas
signific
find
unclear
protein
specif
identifi
also
similar
less
mark
cyclic
abnorr
protein
pattern
also
observ
sera
normal
subject
anoth
studi
serum
protein
pattern
procedur
stain
electrophoreticallysepar
glycoand
lipoprotein
use
compar
sera
patient
ms
patient
herniat
vertebr
disc
normal
subject
increas
lipoprotein
fraction
andor
decreas
lipoprotein
fraction
found
ms
patient
larg
number
patient
herniat
disc
show
similar
abnorm
find
consid
nonspecif
ms
wu
cowork
subject
serum
gradient
polyacrylamid
gel
electrophoresi
observ
distinct
protein
band
ms
specimen
present
control
sera
distinct
band
demonstr
electrophoresi
uniform
gel
protein
purifi
homogen
molecular
weight
assign
confirm
extens
studi
await
interest
minchin
et
al
measur
concentr
wellcharacter
serum
protein
quantit
immunoelectrophoresi
found
differ
ms
patient
normal
subject
dowl
cook
observ
transient
elev
serum
concentr
sever
acutephas
reactant
proactiv
creactiv
protein
orosomucoid
ms
patient
exacerb
later
report
group
concentr
fourth
compon
classic
complement
pathway
also
elev
ms
patient
relaps
wherea
mar
et
al
found
level
significantli
higher
serum
ms
patient
stabl
diseas
patient
fluctuat
clinic
cours
concentr
fell
normal
level
relaps
within
week
afterward
serum
hemolyt
activ
found
normal
ms
patient
wherea
activ
csf
substanti
decreas
patient
sever
activ
diseas
despit
observ
suggest
measur
select
acutephas
protein
might
valu
assess
diseas
activ
ms
patient
receiv
widespread
accept
earli
report
serum
ceruloplasmin
level
measur
oxidas
activ
elev
patient
ms
confirm
immunoelectrophoresi
use
rastogi
cowork
report
abnorm
serum
patient
definit
probabl
ms
cross
immunoelectrophoresi
result
asymmetr
immunoprecipit
suggest
presenc
ms
serum
two
speci
slightli
differ
electrophoret
mobil
similar
antigen
sera
patient
neurolog
diseas
ms
also
show
abnorm
immunoprecipit
isoelectr
focus
isol
ms
sera
reveal
extra
band
isoelectr
point
abl
bind
alter
catalyt
specif
number
circul
proteas
author
specul
find
might
somehow
relat
increas
acid
proteas
activ
numer
other
observ
plaqu
white
matter
patient
ms
find
ofrastogi
et
al
question
bridg
cowork
suggest
procedur
use
demonstr
abnorm
speci
may
led
artifact
furthermor
bridg
cowork
found
differ
normal
ms
subject
regard
abil
bind
trypsin
abil
complex
hydrolys
artifici
substrat
point
even
find
rastogi
et
al
confirm
signific
abnorm
speci
individu
ms
clear
sinc
proteas
bind
ms
serum
appear
normal
although
mean
level
prealbumin
csf
ms
patient
found
twice
control
signific
differ
found
serum
concentr
elev
serum
titr
interferon
report
patient
definit
ms
children
acut
enceph
patient
noninflammatori
nervou
system
diseas
presum
healthi
blood
donor
signific
blood
titr
signific
interferon
titr
csf
regularli
associ
signific
titr
serum
high
serum
titr
detect
without
detect
csf
titr
quantit
correl
found
interferon
level
serum
csf
individu
case
author
suggest
ms
might
way
link
viru
infect
one
agent
known
stimul
product
releas
interferon
howev
other
found
reduc
interferon
product
vitro
lymphocyt
ms
patient
number
type
interferon
recogn
differ
result
may
explain
fact
serum
interferon
measur
viral
induct
wherea
vitro
studi
assay
mitogeninduc
interferon
product
rieder
et
al
report
onethird
group
ms
patient
moder
elev
level
glutamyltransferas
activ
sera
alcohol
intak
caus
unlik
subject
difficulti
establish
refer
rang
glutamyltransferas
activ
mani
factor
affect
activ
includ
neurolog
disord
review
signific
regard
ms
find
rieder
cowork
therefor
question
exampl
author
found
higher
level
activ
older
ms
patient
known
refer
rang
glutamyltransferas
activ
increas
age
deficit
intestin
isozym
alkalin
phosphatas
observ
sera
ms
patient
northern
england
particularli
strike
patient
blood
group
display
intestin
isozym
compar
ford
blood
group
control
presenc
absenc
intestin
isozym
normal
subject
known
relat
abo
blood
group
subject
significantli
increas
incid
type
among
ms
patient
northern
england
also
found
found
larg
group
patient
unit
state
suggest
popul
north
england
might
character
high
frequenc
blood
group
might
also
character
predisposit
ms
unrel
reason
plasma
erythrocyt
glutathion
peroxidas
activ
found
similar
among
patient
ms
patient
neurolog
diseas
normal
subject
result
studi
conduct
great
britain
differ
significantli
lower
level
enzym
activ
observ
ms
patient
denmark
israel
glutathion
peroxidas
seleniumcontain
enzym
anim
activ
affect
selenium
intak
whatev
reason
differ
result
obtain
three
countri
doubt
defici
either
selenium
glutathion
peroxidas
activ
contribut
etiolog
pathogenesi
ms
mehlert
et
al
point
decreas
level
glutathion
peroxidas
activ
report
sever
area
world
without
associ
patholog
condit
iii
immunoglobulin
robert
measur
serum
level
immunoglobulin
class
larg
group
ms
patient
control
orkney
island
extrem
high
incid
ms
asid
slight
increas
mean
concentr
ige
patient
rural
area
signific
differ
found
pandey
et
al
observ
differ
ms
patient
control
frequenc
igg
heavi
chain
allotyp
serum
gm
gene
encod
either
two
allel
heavi
chain
within
igg
subclass
human
caucasian
gm
phenotyp
almost
four
time
like
develop
ms
without
suggest
find
evid
addit
predomin
certain
hla
phenotyp
ms
patient
exampl
abnorm
immun
respons
patient
ms
rickettsi
antibodi
found
sera
mani
patient
ms
uncontrol
studi
franc
howev
control
investig
unit
kingdom
substanti
find
possibl
rickettsi
infect
may
way
involv
pathogenesi
ms
rais
report
hungari
sera
ms
patient
ageand
sexmatch
control
contain
rickettsialspecif
antibodi
posit
sera
contain
antibodi
r
mooseri
possibl
patient
ms
may
suscept
rickettsi
infect
area
rickettsia
indigen
ms
caus
nonspecif
stimul
deregul
previous
acquir
antibodyproduc
cell
report
elev
level
measl
antibodi
sera
patient
ms
continu
appear
whether
level
antibodi
titr
measl
viru
influenc
hla
type
individu
patient
subject
disagr
studi
fail
find
signific
differ
measl
antibodi
titr
ms
patient
control
group
poskanz
et
al
carri
serolog
survey
antibodi
titr
virus
includ
measl
among
inhabit
orkney
shetland
island
area
extrem
high
incid
ms
consist
pattern
antibodi
level
presenc
absenc
antibodi
found
ms
patient
compar
two
control
group
isol
island
mean
age
acquisit
childhood
viral
infect
includ
measl
older
inhabit
mani
part
world
interest
patient
contract
clinic
measl
year
onset
ms
author
conclud
result
fail
incrimin
virus
test
etiolog
ms
possibl
associ
exposur
household
pet
ms
number
investig
measur
serum
antibodi
titr
canin
distem
per
viru
cook
cowork
madden
et
al
found
elev
level
antibodi
measl
distemp
virus
ms
patient
compar
ageand
sexmatch
control
measl
canin
distemp
virus
highli
relat
antigen
base
inabl
demonstr
specif
canin
distemp
viru
antibodi
sera
ms
patient
suggest
reactiv
measl
antibodi
assay
canin
distemp
viru
antibodi
explain
result
studi
show
elev
titr
latter
viru
canin
distemp
viru
unlik
involv
etiolog
ms
bray
et
al
observ
ms
patient
display
significantli
higher
incid
seroposit
epsteinbarr
viru
compar
control
lower
incid
seroposit
cytomegaloviru
compar
control
two
group
report
signific
differ
ms
patient
control
serum
antibodi
titr
sever
mous
human
coronavirus
summari
mani
patient
ms
significantli
higher
serum
antibodi
titr
measl
viru
control
find
usual
explain
manifest
loss
control
nonspecif
stimul
immun
respons
abnorm
immun
respons
limit
least
judg
examin
serum
sinc
studi
found
antibodi
titr
larg
number
virus
measl
usual
elev
ms
patient
compar
control
true
wider
rang
antivir
antibodi
detect
csf
ms
patient
complementfix
igg
antibodi
antigen
homogen
grey
white
matter
report
occur
frequent
ms
patient
although
titr
usual
higher
csf
similar
antibodi
found
serum
wide
rang
titr
pair
csf
serum
sampl
patient
suggest
synthesi
antibodi
occur
intraand
extrathec
antibrain
antibodi
character
bacteri
absorpt
found
primarili
andor
subclass
ms
patient
antibrain
antibodi
demonstr
appar
due
presenc
serolog
inhibitor
antibrain
antibodi
present
serum
csf
sampl
patient
clinic
definit
ms
correspond
figur
probabl
ms
control
although
antibrain
antibodi
titr
serum
higher
patient
malign
cours
consist
correl
remiss
exacerb
clinic
cours
chang
antibodi
titr
other
use
differ
assay
unabl
demonstr
differ
ms
patient
control
bind
serum
immunoglobulin
homogen
brain
ryberg
claim
assay
nonspecif
bina
igg
obscur
increas
antibrain
antibodi
titr
ms
serum
detect
complement
fixat
techniqu
clausen
observ
bind
f
ab
moieti
serum
igg
ms
patient
normal
subject
subcellular
fraction
brain
tissu
obtain
autopsi
patient
without
ms
bind
antibodi
ms
serum
cytosol
protein
ms
brain
twice
great
bind
antibodi
cytosol
protein
nonm
brain
greater
bind
antibodi
normal
sera
ms
cytosol
protein
antibodi
ms
patient
normal
subject
bound
equal
well
control
cytosol
protein
particul
fraction
brain
tissu
result
other
use
cross
immunoelectrophoresi
suggest
ms
serum
contain
antibodi
antigen
cytosol
ms
brain
tissu
arnon
cowork
prepar
liposom
contain
purifi
gangliosid
observ
serum
patient
definit
ms
caus
complementdepend
lysi
liposom
liposom
contain
major
myelin
gangliosid
gm
major
brain
gangliosid
lyse
greatest
extent
sera
normal
subject
caus
signific
lysi
correl
extent
lysi
sever
ms
could
definit
establish
mullin
et
al
hand
unabl
demonstr
signific
p
differ
lysi
gmcontain
liposom
ms
control
sera
also
releas
ofgangliosid
ms
sera
seem
complementdepend
conflict
result
two
studi
may
due
fact
differ
assay
use
assess
liposom
lysi
frick
stickl
observ
serum
ms
patient
stimul
antibodydepend
lymphocyt
cytotox
erythrocyt
presenc
myelin
basic
protein
cerebrosid
gangliosid
encephalitogen
peptid
latter
peptid
repres
region
myelin
basic
protein
administr
suscept
anim
follow
experiment
allerg
encephalomyel
lysi
presenc
encephalitogen
peptid
three
substanc
highli
specif
ms
fals
posit
rate
patient
neurolog
diseas
also
sensit
ms
patient
give
posit
result
depend
diseas
activ
high
degre
specif
sensit
lytic
respons
presenc
peptid
led
author
suggest
reaction
might
pathogenet
role
ms
two
recent
studi
found
substanti
number
ms
patient
control
subject
possess
serum
antibodi
myelin
basic
protein
incid
titr
antibodi
distinguish
two
group
earlier
result
obtain
investig
reghrd
titr
even
presenc
antibodi
summar
ruutiainen
et
al
point
differ
antigen
prepar
use
differ
ms
popul
studi
differ
popul
use
control
differ
antibodi
assay
use
may
contribut
variat
result
report
similar
set
explan
put
forward
mani
conflict
observ
report
patient
ms
paterson
cowork
report
presenc
serum
ms
patient
control
substanc
combin
vari
affin
antibodi
myelin
basic
protein
antimyelin
basic
protein
antibodi
vari
affin
myelin
basic
protein
also
detect
ms
normal
sera
affin
substanc
usual
lower
affin
antibodi
usual
higher
patient
activ
ms
normal
subject
author
suggest
circul
substanc
might
function
restrict
potenti
injuri
myelinbasicproteinreact
lymphoid
cell
clone
number
investig
believ
bind
serum
immunoglobulin
oligodendrocyt
glial
cell
nonspecif
usual
studi
distinguish
featur
ms
indirect
studi
indic
bind
reaction
due
presenc
fc
receptor
oligodendrocyt
reaction
therefor
nonspecif
furthermor
point
use
bovin
oligodendrocyt
prepar
demonstr
antibodi
human
sera
direct
human
oligodendrocyt
may
result
failur
identifi
specif
pathogenet
relev
immun
respons
ms
patient
interspeci
differ
cell
surfac
characterist
two
group
consid
assay
system
specif
regard
antibodi
glial
cell
singh
mashal
found
glialcellbind
antibodi
ms
sera
examin
claim
reaction
specif
glial
cell
cultur
system
bind
occur
sera
normal
subject
patient
neurolog
diseas
use
mar
report
serum
ms
patient
capabl
initi
specif
antibodydepend
lymphocytemedi
cellular
toxic
rat
glial
tumour
cell
line
gliotoxicstimul
activ
found
significantli
higher
ms
sera
normal
sera
sera
patient
neurolog
diseas
gliotox
activ
tissuespecif
glial
cell
greatest
patient
chronic
progress
ms
least
stabl
diseas
variou
antibrain
antibodi
play
role
pathogenesi
ms
strong
case
made
ms
diseas
immun
regul
hypothesi
true
princip
question
must
answer
concern
natur
neural
antigen
involv
present
clearcut
answer
question
avail
reason
given
inconclus
result
thu
far
obtain
especi
tell
argument
pathogenet
role
antibrain
antibodi
describ
instanc
substanti
proport
patient
ms
appear
antibodi
present
normal
subject
neurolog
diseas
mani
worker
search
lymphocytotox
antibodi
serum
ms
patient
schocket
et
al
found
incid
coldreact
lymphocytotox
antibodi
significantli
increas
ms
patient
compar
sibl
patient
neurolog
diseas
normal
subject
level
correl
significantli
serum
measl
antibodi
titr
clinic
cours
worker
confirm
coldreact
lymphocytotox
antibodi
found
frequent
ms
patient
control
scott
et
al
absorb
sera
pool
human
platelet
attempt
remov
interf
antihla
antibodi
absorpt
ms
sera
control
sera
remain
lymphocytotox
cytotox
greatest
toward
suppressor
cell
defin
monoclon
antibodi
ms
sera
posit
lymphotoxin
patient
activ
progress
diseas
tsukamoto
cowork
also
observ
mark
increas
incid
antibodi
ms
patient
period
increas
diseas
activ
patient
posit
other
observ
correl
suggest
antibodi
may
marker
viral
infect
associ
ms
may
play
role
modul
immun
respons
armentrout
et
al
report
presenc
ms
serum
factor
necessarili
antibodi
inhibit
mitogeninduc
blast
transform
human
lymphocyt
cell
sensit
inhibitori
factor
degre
inhibit
produc
patient
serum
correl
level
clinic
diseas
activ
contrari
result
report
mogensen
cowork
found
serum
patient
ms
less
inhibitori
mitogenstimul
lymphocyt
transform
serum
patient
neurolog
diseas
issu
import
one
sinc
consider
evid
accumul
abnorm
immunoregulatori
lymphocyt
occur
ms
number
neurolog
diseas
state
mani
antibodi
factor
assay
sera
ms
patient
tabl
result
list
tabl
abnorm
found
consist
ms
sera
inhibit
leukocyt
adher
posit
result
observ
patient
ms
control
subject
howev
unusu
sensit
specif
leukocyt
adher
inhibit
assay
ms
confirm
worker
oligoclon
band
demonstr
presum
igg
observ
serum
patient
ms
number
investig
olsson
nilsson
subject
serum
csf
isoelectr
focus
found
band
serum
correspond
csf
present
ms
patient
band
serum
fainter
author
suggest
deriv
csf
report
confirm
earlier
work
laurenzi
link
observ
oligoclon
band
serum
ms
patient
oligoclon
band
serum
rare
demonstr
agaros
gel
electrophoresi
less
sensit
isoelectr
focus
mehta
et
al
report
ms
patient
oligoclon
band
igg
sera
isoelectr
focus
band
pattern
gener
similar
csf
later
work
group
howev
show
individu
ms
patient
major
oligoclon
band
serum
differ
respect
number
isoelectr
point
light
chain
type
band
seen
patient
csf
nagelkerken
et
al
prepar
antisera
react
specif
csf
oligoclon
igg
csf
antigen
oligoclon
igg
enrich
rel
total
igg
suggest
intrathec
synthesi
howev
absolut
concentr
antigen
igg
higher
serum
csf
suggest
least
portion
synthes
outsid
cn
investig
unabl
demonstr
crossreact
igg
band
differ
patient
support
view
least
oligoclon
band
antibodi
uniqu
individu
crossreact
band
serum
csf
patient
observ
find
similar
nagelkerken
et
al
report
baird
cowork
also
note
uniqu
idiotyp
igg
patient
ms
persist
fiveyear
period
find
suggest
continu
stimul
unknown
antigen
occur
vartdal
et
al
use
highli
sensit
electroimmunofix
method
found
notabl
differ
ms
patient
ageand
sexmatch
control
frequenc
oligoclon
serum
antibodi
varieti
bacteri
viral
antigen
oligoclon
antibodi
associ
oligoclon
band
igg
demonstr
serum
csf
isoelectr
focus
circul
immun
complex
found
sera
onethird
ms
patient
patzold
cowork
csf
sampl
immun
complex
observ
equal
frequenc
acut
exacerb
stabl
phase
diseas
frequent
patient
longstand
diseas
patient
immun
complex
tend
exhibit
rapid
clinic
deterior
latter
observ
confirm
jan
et
al
trouilla
cowork
detect
immun
complex
sera
patient
ms
first
degre
rel
could
find
associ
clinic
cours
ms
presenc
absenc
complex
hail
et
al
confirm
high
incid
immun
complex
sera
ms
patient
unaffect
rel
find
suggest
elev
level
ms
patient
may
famili
phenomenon
relat
common
environment
genet
factor
arnadottir
cowork
carri
extens
longitudin
studi
serum
csf
immun
complex
ms
patient
unabl
discern
clear
correl
presenc
quantiti
fluctuat
complex
clinic
cours
diseas
conclud
complex
precipit
factor
pathogenesi
ms
worker
went
character
immun
complex
ms
patient
antigenspecif
immun
complex
radioimmunoassay
detect
presenc
myelin
membranerel
antigen
signific
correl
observ
serum
level
immun
complex
detect
standard
method
clq
reactiv
myelin
membranerel
antigen
buoyant
densiti
antigen
complex
sucros
gradient
centrifug
suggest
contain
lipid
work
requir
establish
role
specif
immun
complex
ms
obvious
hope
character
antigen
moieti
complex
lead
understand
neural
antigen
import
pathogenesi
ms
diseas
autoimmun
dasgupta
cowork
noronha
et
al
observ
significantli
higher
incid
immun
complex
serum
ms
patient
activ
diseas
compar
remiss
result
differ
mani
earlier
studi
suggest
pathogenet
role
immun
complex
explain
due
applic
sensit
assay
previous
use
conflict
result
report
concern
incid
specif
pathogenet
import
substanc
csf
serum
ms
patient
demyelin
nerv
inhibit
electr
conduct
bornstein
cowork
claim
serum
patient
activ
ms
produc
demyelin
cultur
cn
tissu
major
portion
demyelin
activ
associ
serum
immunoglobulin
ulrich
lardi
report
sera
patient
varieti
neurolog
diseas
ms
ms
patient
posit
demyelin
activ
seil
et
al
found
serum
sampl
ms
patient
demyelin
agreement
result
bornstein
cowork
correl
observ
serum
demyelin
activ
diseas
activ
author
specul
serum
demyelin
activ
epiphenomenon
directli
relat
pathogenesi
ms
suggest
neuroelectr
block
factor
present
serum
csf
ms
patient
attract
sinc
offer
explan
transient
neurolog
defect
occur
breviti
fluctuat
neurolog
sign
symptom
often
incompat
time
requir
demyelin
follow
remyelin
schauf
davi
use
test
system
isol
spinal
cord
frog
although
unabl
demonstr
ford
effect
ms
sera
conduct
either
normal
demyelin
nerv
observ
blockad
ventral
root
respons
serum
ms
patient
level
neuroelectr
block
activ
correl
variat
cours
diseas
present
normal
serum
observ
serum
patient
amyotroph
later
sclerosi
hand
seil
cowork
review
refer
conclud
evid
indic
neuroelectr
block
factor
play
role
human
neurolog
diseas
investig
use
mous
cerebr
neocortex
cultur
test
system
found
neuroelectr
block
factor
specif
demyelin
diseas
factor
present
high
proport
normal
sera
larg
number
observ
made
concern
presenc
absenc
abnorm
serum
plasma
patient
ms
unfortun
extens
collect
inform
contribut
major
coher
way
understand
etiolog
pathogenesi
disord
clearer
pictur
caus
ms
emerg
perhap
recogn
import
certain
abnorm
current
regard
nonspecif
epiphenomena
furthermor
none
report
chang
prove
suffici
reliabl
distinct
gain
statu
diagnost
prognost
test
may
sensit
specif
abnorm
associ
ms
subtl
suspect
appear
appreci
extent
serum
plasma
altern
ms
may
multipl
etiolog
pathogenes
although
produc
recogniz
clinic
pictur
lead
singl
characterist
abnorm
serum
plasma
